Contractor
CHARTWELL RX LLC
- UEI
- ER5UA9TYBGH4
- Parent UEI
- ER5UA9TYBGH4
- Resolved by
- uei
- Confidence
- 1.000
Active from Jun 18, 2025 to Sep 29, 2026.
Sign in to watchRecent awards
| Award | Agency | Place | First action | Current value |
|---|---|---|---|---|
| 75A50326C00010 BULK PHARMACEUTICAL BUY FOR SNS WAREHOUSES (CHARTWELL RX, LLC) | Department of Health and Human Services | NY | Sep 29, 2026 | $21,932,640 |
| 75A50325F80009 DOXYCYCLINE HYCLATE 100 MG ORAL TABLETS | Department of Health and Human Services | NY | Jun 18, 2025 | $144,579,702 |
| 36F79720D0198 UPDATE ESTIMATED VALUE | Department of Veterans Affairs | — | Jul 7, 2026 | — |
| SPE2D326F103G 4571753692!ONDANSETRON ODT 4 MG TABLET 30S | Department of Defense | NY | May 7, 2026 | $110 |
| SPE2D326F101T 4571753693!ONDANSETRON ODT 8 MG TABLET 30S | Department of Defense | NY | May 7, 2026 | $2,753 |
| SPE2D326F093F 4571726909!DOXYCYCLINE HYCLATE 100 MG TAB 1000S | Department of Defense | NY | May 5, 2026 | $292 |
| SPE2D326F090G 4571705931!DOXYCYCLINE HYCLATE 100 MG TAB 1000S | Department of Defense | NY | May 4, 2026 | $175 |
| SPE2D326F089H 4571705933!ONDANSETRON ODT 4 MG TABLET 30S | Department of Defense | NY | May 4, 2026 | $330 |
| SPE2D326F089Q 4571705930!ONDANSETRON ODT 4 MG TABLET 30S | Department of Defense | NY | May 4, 2026 | $330 |
| SPE2D326F084Z 4571686322!ONDANSETRON ODT 4 MG TABLET 30S | Department of Defense | NY | May 1, 2026 | $1,322 |
| SPE2D326F070R 4571655694!ONDANSETRON ODT 4 MG TABLET 30S | Department of Defense | NY | Apr 29, 2026 | $330 |
| SPE2D326F072P 4571663729!ONDANSETRON ODT 8 MG TABLET 30S | Department of Defense | NY | Apr 29, 2026 | $367 |
| SPE2D326F072X 4571663728!ONDANSETRON ODT 8 MG TABLET 30S | Department of Defense | NY | Apr 29, 2026 | $184 |
| SPE2D326F070Z 4571655693!DOXYCYCLINE HYCLATE 100 MG TAB 1000S | Department of Defense | NY | Apr 29, 2026 | $175 |
| SPE2D326F068Q 4571642771!ONDANSETRON ODT 4 MG TABLET 30S | Department of Defense | NY | Apr 28, 2026 | $881 |
| SPE2D326F058U 4571606073!ONDANSETRON ODT 4 MG TABLET 30S | Department of Defense | NY | Apr 24, 2026 | $220 |
| SPE2D326F056V 4571590797!ONDANSETRON ODT 8 MG TABLET 30S | Department of Defense | NY | Apr 23, 2026 | $8,258 |
| SPE2D326F050E 4571574859!ONDANSETRON ODT 8 MG TABLET 30S | Department of Defense | NY | Apr 22, 2026 | $1,835 |
| SPE2D326F041X 4571559122!ONDANSETRON ODT 4 MG TABLET 30S | Department of Defense | NY | Apr 21, 2026 | $551 |
| SPE2D326F038J 4571542450!ONDANSETRON ODT 4 MG TABLET 30S | Department of Defense | NY | Apr 20, 2026 | $220 |
| SPE2D326F039C 4571542451!ONDANSETRON ODT 4 MG TABLET 30S | Department of Defense | NY | Apr 20, 2026 | $661 |
| SPE2D326F035K 4571520013!ONDANSETRON ODT 4 MG TABLET 30S | Department of Defense | NY | Apr 17, 2026 | $551 |
| SPE2D326F030M 4571519605!ONDANSETRON ODT 4 MG TABLET 30S | Department of Defense | NY | Apr 16, 2026 | $1,432 |
| SPE2D326F030T 4571519604!ONDANSETRON ODT 8 MG TABLET 30S | Department of Defense | NY | Apr 16, 2026 | $2,202 |
| SPE2D326F024R 4571489763!TERBINAFINE HCL 250 MG TABLET 30S | Department of Defense | NY | Apr 14, 2026 | $120 |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
Totals sum obligations across every award attributed to this contractor. Obligations are cumulative funding actions, not the value of work delivered.
- 1Awards are attributed by Unique Entity Identifier ER5UA9TYBGH4, the government's own recipient identifier, not by name matching.
- 2Award records from USAspending.gov, last refreshed Oct 21, 2026.